A synthetic peptide for use as a blocking control in assays to test for specificity of FANCA antibody, Alternative Names: FANCA control peptide, FANCA antibody Blocking Peptide, Anti-FANCA Blocking Peptide, Fanconi Anemia Complementation Group A Blocking Peptide, FA Blocking Peptide, FA-H Blocking Peptide, FA1 Blocking Peptide, FAA Blocking Peptide, FACA Blocking Peptide, FAH Blocking Peptide, FANCH Blocking Peptide, MGC75158 Blocking Peptide
FANCA
Reactivité: Humain, Souris, Rat
Hôte: Synthetic
BP
Indications d'application
Optimal conditions should be determined by the investigator
Restrictions
For Research Use only
Format
Lyophilized
Reconstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Conseil sur la manipulation
Avoid repeated freeze/thaw cycles.
Stock
-20 °C
Stockage commentaire
Store at -20 °C long term.
Antigène
FANCA
(Fanconi Anemia Group A Protein (FANCA))
Synonymes
FA Peptide, FA-H Peptide, FA1 Peptide, FAA Peptide, FACA Peptide, FAH Peptide, FANCH Peptide, AW208693 Peptide, Fanconi anemia complementation group A Peptide, Fanconi anemia, complementation group A Peptide, FANCA Peptide, Fanca Peptide
Sujet
The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1, FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ, FANCL, FANCM and FANCN. The previously defined group FANCH is the same as FANCA. Fanconi anemia is a genetically heterogeneous recessive disorder characterized by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal breakage, and defective DNA repair.